NCT05883540View on ClinicalTrials.gov

Lysergic Acid Diethylamide (LSD) in Palliative Care

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 9, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

May 31, 2028

Conditions
Palliative CarePainAnxietyDepressionDemoralizationPsychological DistressQuality of LifeCaregiver BurdenFear of DeathExistential Distress
Interventions
DRUG

Lysergic Acid Diethylamide Tartrate

25 μg p.o.

DRUG

Lysergic Acid Diethylamide Tartrate

100 or 200 μg p.o.

Trial Locations (3)

8610

RECRUITING

Spital Uster AG, Uster

Unknown

RECRUITING

University Hospital Basel, Basel

RECRUITING

University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative Care, Zurich

All Listed Sponsors
collaborator

University Hospital, Zürich

OTHER

collaborator

Spital Uster AG, Uster, Switzerland

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER